Farname Inc. in collaboration with Iranian Society of Gynecology Oncology

Authors

1 Department of Obstetrics and Gynocology, Imam Hossein Hospital, Kermanshah, Iran

2 Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

3 Department of Obstetrics and Gynocology, Sarem Hospital, Iran University of Medical Sciences, Tehran, Iran

4 Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Pelvic infections are among the most prevalent and serious postpartum complications. Over the past several decades, these infections, along with preeclampsia and hemorrhage, have constituted the triad of death among mothers. The presence of meconium in the amniotic fluid has been considered as one of the risk factors for postpartum infections. This study aimed to investigate the association of meconium-stained amniotic fluid with postpartum infection and fever.
Methods: This prospective cohort study included 200 singleton term pregnant women, referred for childbirth to Imam Khomeini and Razi hospitals of Ahvaz in 2014. The women were assigned to two groups, ie, subjects with meconium-stained amniotic fluid (exposure group) and subjects with clear amniotic fluid (control group). The participants in the two groups were identical in terms of maternal age, gestational age, parity, and duration of ruptured membranes. Pregnant women who had underlying medical problems were excluded from the study. Both groups received intravenous ampicillin half an hour before the surgery until 48 hours after the surgery, based on the protocol introduced by the hospital for women planning cesarean section. The two groups were compared regarding post-C. Section infection. The exposure group consisted of 100 subjects with meconium-stained amniotic fluid, while the control group included 100 subjects with clear amniotic fluid. The participants were observed for maternal prognosis, based on postpartum infections.
Results: Both groups underwent C-section. In the exposure and control groups, 14 (14%) and 12 (12%) women had fever after C-section, respectively. Moreover, 6 (6%) and 3 (3%) women in the exposure and control groups had post-C. section wound infections, respectively.
Conclusions: No significant difference was found in post-C. Section fever and wound infection between the two groups, which might be related to the duration of intravenous antibiotic administration. To examine the effects of intravenous antibiotics, further studies should be conducted. In both groups, the highest incidence of fever was observed among women younger than 20 years; this result was statistically significant.

Keywords

  1. Tran SH, Caughey AB, Musci TJ. Meconium-stained amniotic fluid is associated with puerperal infections. Am J Obstet Gynecol. 2003;189(3):746-50. [DOI:10.1067/S0002-9378(03)00767-1]
  2. Rosene K, Eschenbach DA, Tompkins LS, Kenny GE, Watkins H. Polymicrobial early postpartum endometritis with facultative and anaerobic bacteria, genital mycoplasmas, and Chlamydia trachomatis: treatment with piperacillin or cefoxitin. J Infect Dis. 1986;153(6):1028-37. [DOI:10.1093/infdis/153.6.1028] [PMID]
  3. Hoyme UB, Kiviat N, Eschenbach DA. Microbiology and treatment of late postpartum endometritis. Obstet Gynecol. 1986;68(2):226-32.
  4. Ismail MA, Moawad AH, Poon E, Henderson C. Role of Chlamydia trachomatis in postpartum endometritis. J Reprod Med. 1987;32(4):280-4.
  5. Hofmeyr GJ, Smaill FM. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev. 2002(3). [DOI:10.1002/14651858.CD000933]
  6. D'Angelo LJ, Sokol RJ. Time-related peripartum determinants of postpartum morbidity. Obstet Gynecol. 1980;55(3):319-23. [DOI:10.1097/00006250-198003000-00010] [PMID]
  7. Bobitt JR, Ledger WJ. Amniotic fluid analysis. Its role in maternal neonatal infection. Obstet Gynecol. 1978;51(1):56-62. 8. Jazayeri A, Jazayeri MK, Sahinler M, Sincich T. Is meconium passage a risk factor for maternal infection in term pregnancies?. Obstet Gynecol. 2002;99(4):548-52. https://doi.org/10.1097/00006250-200204000-00006 [DOI:10.1016/S0029-7844(01)01786-0]
  8. Whitfield JM, Charsha DS, Chiruvolu A. Prevention of meconium aspiration syndrome: an update and the Baylor experience. Proc (BaylUniv Med Cent). 2009;22(2):128-31. [DOI:10.1080/08998280.2009.11928491] [PMID]
  9. Balchin I, Whittaker JC, Lamont RF, Steer PJ. Maternal and fetal characteristics associated with meconium-stained amniotic fluid. Obstet Gynecol. 2011;117(4):828-35. [DOI:10.1097/AOG.0b013e3182117a26] [PMID]
  10. Yamada T, Minakami H, Matsubara S, Yatsuda T, Kohmura Y, SatoI. Meconium-stained amniotic fluid exhibits chemotactic activity for polymorphonuclear leukocytes in vitro. J Reprod Immunol. 2000;46(1):21-30. [DOI:10.1016/S0165-0378(99)00048-0]
  11. Mazor M, Furman B, Wiznitzer A, Shoham-Vardi I, Cohen J, Ghezzi F. Maternal and perinatal outcome of patients with preterm labor and meconium-stained amniotic fluid. Obstet Gynecol. 1995;86(5):830-3. [DOI:10.1016/0029-7844(95)00265-S]
  12. Bryan CS. Enhancement of bacterial infection by meconium. Johns Hopkins Med J. 1967;121(1):9.
  13. Duff P. Pathophysiology and management of postcesarean endoometritis. Obstet Gynecol. 1986;67(2):269-76. [DOI:10.1097/00006250-198602000-00021] [PMID]
  14. Florman AL, Teubner D. Enhancement of bacterial growth in amniotic fluid by meconium. J Pediatr. 1969;74(1):111-4. [DOI:10.1016/S0022-3476(69)80016-8]
  15. Clark P, Duff P. Inhibition of neutrophil oxidative burst and phagocytosis by meconium. Am J Obstet Gynecol. 1995;173(4):1301-5. [DOI:10.1016/0002-9378(95)91375-0]
  16. Rahimi Sharbaf F, Davari Tanha F, Niromansh S. Meconium- stained amniotic fluid as an independent risk factor for fever and postpartum infection in term pregnancy. Tehran Univ Med J. 2008;66(3):203-7.
  17. Hiersch L, Krispin E, Aviram A, Wiznitzer A, Yogev Y, Ashwal E. Effect of Meconium-Stained Amniotic Fluid on Perinatal Complications in Low-Risk Pregnancies at Term. Am J Perinatol. 2016;33(4):378-84. [DOI:10.1055/s-0035-1565989] [PMID]
  18. Shirazi M, Shahbazi F, Pirzadeh L, Mohammadi SR, Ghaffari P, Eftekhar T. Tuberculosis endometritis presenting as a leiomyoma. Int J Fertil Steril. 2015;8(4):481-4.
  19. Shirazi M, Abbariki E, Hafizi A, Shahbazi F, Bandari M, Dastgerdy E. The prevalence of group B streptococcus colonization in Iranian pregnant women and its subsequent outcome. Int J Fertil Steril. 2014;7(4):267-70.
  20. Sarani M, Shahraki Z, Shirazi M, Saravani S. Risk factors of maternal mortality in Sistan region: 10-year report [In Persion]. Tehran Univ Med J. 2014;72(9):623-9.